Skip to main content
. 2015 Oct 26;71(1):99–107. doi: 10.1111/all.12760

Figure 4.

Figure 4

Increase in nasal flow (l/min) after 5 months of treatment compared to baseline in the full analysis set (least square mean change from baseline in PNIF ± SE). *The change in PNIF compared to placebo was significant in the 40 000 AUN/ml group.